JP2020511284A5 - - Google Patents

Download PDF

Info

Publication number
JP2020511284A5
JP2020511284A5 JP2019568589A JP2019568589A JP2020511284A5 JP 2020511284 A5 JP2020511284 A5 JP 2020511284A5 JP 2019568589 A JP2019568589 A JP 2019568589A JP 2019568589 A JP2019568589 A JP 2019568589A JP 2020511284 A5 JP2020511284 A5 JP 2020511284A5
Authority
JP
Japan
Prior art keywords
cellulite
scale
severity
pcss
class
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019568589A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020511284A (ja
JP7558654B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/020551 external-priority patent/WO2018160905A1/en
Publication of JP2020511284A publication Critical patent/JP2020511284A/ja
Publication of JP2020511284A5 publication Critical patent/JP2020511284A5/ja
Priority to JP2023094087A priority Critical patent/JP2023120246A/ja
Application granted granted Critical
Publication of JP7558654B2 publication Critical patent/JP7558654B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019568589A 2017-03-01 2018-03-01 セルライトを評価及び処置するための装置及び方法 Active JP7558654B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023094087A JP2023120246A (ja) 2017-03-01 2023-06-07 セルライトを評価及び処置するための装置及び方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762465622P 2017-03-01 2017-03-01
US62/465,622 2017-03-01
US201762485705P 2017-04-14 2017-04-14
US62/485,705 2017-04-14
US201762607188P 2017-12-18 2017-12-18
US62/607,188 2017-12-18
PCT/US2018/020551 WO2018160905A1 (en) 2017-03-01 2018-03-01 Apparatus and method for assessing and treating cellulite

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023094087A Division JP2023120246A (ja) 2017-03-01 2023-06-07 セルライトを評価及び処置するための装置及び方法

Publications (3)

Publication Number Publication Date
JP2020511284A JP2020511284A (ja) 2020-04-16
JP2020511284A5 true JP2020511284A5 (https=) 2021-04-08
JP7558654B2 JP7558654B2 (ja) 2024-10-01

Family

ID=61768443

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019568589A Active JP7558654B2 (ja) 2017-03-01 2018-03-01 セルライトを評価及び処置するための装置及び方法
JP2023094087A Pending JP2023120246A (ja) 2017-03-01 2023-06-07 セルライトを評価及び処置するための装置及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023094087A Pending JP2023120246A (ja) 2017-03-01 2023-06-07 セルライトを評価及び処置するための装置及び方法

Country Status (17)

Country Link
US (4) US11123280B2 (https=)
EP (2) EP4591945A3 (https=)
JP (2) JP7558654B2 (https=)
KR (3) KR102610801B1 (https=)
CN (2) CN110545722B (https=)
AU (4) AU2018226820B2 (https=)
BR (1) BR112019018277A2 (https=)
CA (1) CA3055041A1 (https=)
DK (1) DK3589204T3 (https=)
ES (1) ES3036011T3 (https=)
FI (1) FI3589204T3 (https=)
HU (1) HUE072115T2 (https=)
IL (2) IL301796A (https=)
MX (2) MX2023015506A (https=)
PL (1) PL3589204T3 (https=)
PT (1) PT3589204T (https=)
WO (1) WO2018160905A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2802652T (pt) 2012-01-12 2019-09-10 Endo Global Ventures Enzimas de clostridium histolyticum
EP4591945A3 (en) 2017-03-01 2026-04-15 Endo Operations Limited Apparatus and method for assessing and treating cellulite
JP7227918B2 (ja) 2017-03-28 2023-02-22 エンド ベンチャーズ リミテッド コラゲナーゼ産生の改良された方法
WO2020021330A2 (en) 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
WO2020021332A2 (en) 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
US20240277595A1 (en) * 2018-09-18 2024-08-22 Endo Global Aesthetics Limited Compositions and methods for treating cellulite
US20220305094A1 (en) * 2019-01-06 2022-09-29 Endo Global Aesthetics Limited Collagenase formulations and methods of producing the same
CN118576307A (zh) 2019-03-13 2024-09-03 布鲁瑟姆斯创新有限公司 插入装置以及确定与患者的至少一个目标组织相关联的信息的方法
US11432733B2 (en) 2019-03-13 2022-09-06 Blossom Innovations Tissue detection devices, systems and methods
US20220095925A1 (en) 2019-03-13 2022-03-31 Blossom Innovations, LLC Devices, systems and methods for tissue analysis, location determination and therapy thereof using optical radiation
WO2021108704A1 (en) 2019-11-27 2021-06-03 Blossom Innovations, LLC Devices, systems and methods for tissue analysis, location determination and tissue ablation
CN113033528A (zh) * 2021-05-27 2021-06-25 明品云(北京)数据科技有限公司 一种反馈量表评估方法、系统、设备和介质

Family Cites Families (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821364A (en) 1966-07-08 1974-06-28 Advance Biofactures Corp Process of producing collagenase
JPS5662229A (en) 1979-10-25 1981-05-28 Asahi Glass Co Ltd Electro-optical dimming panel
US4338300A (en) 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
EP0115974B1 (fr) 1983-01-05 1988-09-07 Institut Pasteur Préparation à activité collagénolytique ayant une activité élevée et compositions pharmaceutiques la contenant
US4645668A (en) 1983-08-04 1987-02-24 Biospecifics, Nv Method for the prevention and treatment of scars with enzymes
US4524065A (en) 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
US5252461A (en) 1990-05-01 1993-10-12 The Regents Of The Univ. Of California Mixed immunoglobulins for detection of rheumatoid factors
CA2047306A1 (en) 1990-07-23 1992-01-24 Milan Holjevac Mutant bacterium clostridium histolyticum, a process for the obtaining thereof, and its use in the production of clostripain-free collagenase
US5393792A (en) 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5462739A (en) 1991-11-21 1995-10-31 Yeda Research And Development Co., Ltd. Microdelivery device and method for enhanced drug administration to the eye
US5256140A (en) 1992-03-27 1993-10-26 Fallien Cosmeceuticals, Ltd. Composition for levelling skin
WO1994000580A1 (en) 1992-06-22 1994-01-06 Trigen, Inc. Molecular cloning of the genes reponsible for collagenase production from clostridium histolyticum
JP3186881B2 (ja) 1993-02-18 2001-07-11 倉敷紡績株式会社 肝細胞の分離方法
US5332503A (en) 1993-04-16 1994-07-26 Baxter International Inc. Process for purifying collagenase
US5514340A (en) 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
CA2189646C (en) 1994-06-24 1999-05-25 Francis E. Dwulet A purified mixture of collagenases and two other proteases obtained from clostridium histolyticum
US5589171A (en) 1994-08-22 1996-12-31 Advance Biofactures Of Curacao Treatment of Dupuytren's disease with collagenase
CA2158822C (en) 1994-09-27 2008-12-23 Kusuki Nishioka Therapeutic agent for rheumatic disease
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
CZ280397A3 (cs) 1995-03-16 1998-04-15 Knoll Aktiengesellschaft Nové, definované směsi enzymů pro získávání buněk a pro léčbu poranění
IT1279011B1 (it) 1995-06-15 1997-12-02 Ips Int Prod Services Apparecchiatura per la rilevazione e scelta dei trattamenti della cellulite
US5705170A (en) * 1995-10-24 1998-01-06 Plantech International, Inc. Herbal cellulite treatments
US5989888A (en) 1996-01-24 1999-11-23 Roche Diagnostics Corporation Purified mixture of collagenase I, collagenase II and two other proteases
ATE272109T1 (de) 1996-11-19 2004-08-15 Roche Diagnostics Gmbh Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden
US5830741A (en) 1996-12-06 1998-11-03 Boehringer Mannheim Corporation Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease
US5753785A (en) 1996-12-16 1998-05-19 Fina Technology, Inc. Production of E-B copolymers with a single metallocene catalyst and a single monomer
US6086872A (en) 1997-03-27 2000-07-11 Advance Biofactures Of Curacao, Nv Amelioration of dupuytren's disease
JPH10262658A (ja) 1997-03-28 1998-10-06 Kikkoman Corp ザルコシン・オキシダーゼの結晶、その製造方法及び三次元構造
US6335388B1 (en) 1997-10-03 2002-01-01 Lavipharm Laboratories Inc. Prolamine-plant polar lipid composition, its method of preparation and applications thereof
GB9724802D0 (en) 1997-11-24 1998-01-21 Unilever Plc Antiperspirant or deodorant compoistions
US20020036328A1 (en) 1998-11-16 2002-03-28 William R. Richards, Jr. Offset drain fermi-threshold field effect transistors
FR2788682B1 (fr) * 1999-01-26 2001-04-06 Seb Sa Dispositif de thermographie
US6022539A (en) 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
RU2180002C2 (ru) 1999-08-16 2002-02-27 Пермское научно-производственное объединение "Биомед" Способ получения коллагеназы
US6358539B1 (en) 1999-08-20 2002-03-19 Howard Murad Pharmaceutical compositions for reducing the appearance of cellulite
US6280993B1 (en) 1999-08-24 2001-08-28 Ichiro Yamato Gene encoding class I collagenase
ITMI991894A1 (it) * 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
CA2385488C (en) 1999-09-24 2015-07-07 Proteon Therapeutics, Inc. Systems and methods for opening obstructed biological conduits
WO2001078687A1 (en) 2000-04-18 2001-10-25 Peptron Inc. Injectable sustained release pharmaceutical composition and processes for preparing the same
JP2004528278A (ja) 2000-12-18 2004-09-16 ボード オブ レジェンツ,ザ ユニバーシティー オブ テキサス システム インサイチュヒドロゲルを用いた、局所領域の化学療法および放射線治療
US20030022856A1 (en) 2001-01-30 2003-01-30 The Regents Of The University Of Michigan Method for sustained release local delivery of drugs for ablation of unwanted tissue
ATE302844T1 (de) 2001-07-02 2005-09-15 Nordmark Arzneimittel Gmbh & C Verfahren zur aufreinigung eines enzyms und hiernach hergestelltes, aufgereinigtes enzym sowie verwendung des enzyms
GB0124124D0 (en) 2001-10-08 2001-11-28 Medical Res Council Methods of treatment
SI2241295T1 (sl) * 2002-03-15 2012-11-30 Gen Hospital Corp Naprave za selektivno razbitje maščobnega tkivaz nadzorovanim hlajenjem
JP2003284553A (ja) 2002-03-28 2003-10-07 Seikagaku Kogyo Co Ltd 生理活性タンパク質
BR0215785A (pt) * 2002-06-25 2006-06-06 Ultrashape Inc dispositivos e metodologias uteis para esteticas do corpo
EP1433845A1 (en) 2002-12-23 2004-06-30 Georg-August-Universität Clostridium tetani collagenase and uses thereof
EP1462519A1 (en) 2003-03-24 2004-09-29 Boehringer Ingelheim Austria GmbH Method and devices for producing biomolecules
JP4205496B2 (ja) 2003-06-19 2009-01-07 三菱化学株式会社 新規カルボニル還元酵素及びこれをコードするdna、ならびにこれらを利用した光学活性アルコールの製造方法
US8536315B2 (en) 2004-01-30 2013-09-17 Shire Pharmaceuticals Ireland Limited Production and purification of recombinant arylsulftase
US8147428B2 (en) * 2004-04-16 2012-04-03 University Of Massachusetts Device and method for quantifying edema
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
ES2660172T3 (es) 2004-05-19 2018-03-21 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Composición inyectable que comprende desoxicolato de sodio
US7355027B2 (en) 2004-06-16 2008-04-08 Dynport Vaccine Company Llc Bacillus anthracis protective antigen
DE602005014117D1 (de) 2004-07-07 2009-06-04 Lundbeck As Valby H Neues carbamyliertes epo und verfahren zu dessen herstellung
WO2006010057A2 (en) 2004-07-08 2006-01-26 Amgen Inc. Therapeutic peptides
WO2006025226A1 (ja) 2004-08-30 2006-03-09 Daicel Chemical Industries, Ltd. ポリグリセリンモノエーテル及びその製造方法
US20150025420A1 (en) * 2004-10-06 2015-01-22 Guided Therapy Systems, Llc Ultrasound treatment device and methods of use
DE102004060075A1 (de) 2004-12-14 2006-07-06 Merck Patent Gmbh Verfahren zur Herstellung von Onium-Salzen mit Dialkylphosphat-, Dialkylphosphinat oder (O-Alkyl)-alkyl- oder Alkyl-phosphonat-Anionen mit geringem Halogenid-Gehalt
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
US7854929B2 (en) 2005-01-21 2010-12-21 The Research Foundation Of State University Of New York Method for treating lateral epicondylitis using collagenase
CN101107006B (zh) 2005-01-21 2013-09-11 纽约州立大学研究基金会 治疗黏连性关节囊炎的方法
JP2006254876A (ja) 2005-03-18 2006-09-28 Hokkaido Univ L−トリプトファン製造法
US20060251581A1 (en) 2005-05-09 2006-11-09 Mcintyre Jon T Method for treatment of uterine fibroid tumors
US20070003541A1 (en) 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
ITPD20050207A1 (it) 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
JP3122177U (ja) * 2005-09-28 2006-06-08 株式会社資生堂 セルライトの診断基準シート
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2007100590A2 (en) 2006-02-22 2007-09-07 Auxilium Pharmaceuticals, Inc. Methods for treating cellulite
EA200802090A1 (ru) * 2006-03-31 2010-04-30 ДСМ АйПи АССЕТС Б.В. Новое применение соединений и комбинаций соединений для улучшения внешнего вида
WO2008100833A2 (en) 2007-02-13 2008-08-21 Auxilium International Holdings, Inc. Production of recombinant collagenases colg and colh in escherichia coli
WO2008101406A1 (en) 2007-02-14 2008-08-28 Yolare Dermaceuticals, Llc Modified mutant collagenase and it's use in fat melting and in scar reduction
EP2152225A1 (en) * 2007-05-11 2010-02-17 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Gel useful for the delivery of cosmetic active ingredients
US9987221B2 (en) 2007-08-23 2018-06-05 Boston Scientific Scimed, Inc. Injectable hydrogel compositions
US20110262508A1 (en) 2007-11-07 2011-10-27 Paul Michael Watt Antimicrobial compositions, formulations and uses thereof
US20100159564A1 (en) 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
ES2388219T3 (es) 2008-06-02 2012-10-10 F. Hoffmann-La Roche Ag Purificación mejorada de colagenasas a partir de un cultivo líquido de Clostridium histolyticum
US8236356B2 (en) 2008-06-11 2012-08-07 Roche Diagnostics Operations, Inc. Growth medium for Clostridium histolyticum
JP5421366B2 (ja) 2008-07-21 2014-02-19 オトノミ―,インク. 制御放出性の耳の構造体調節および生来の免疫システム調節化合物および耳の障害の処置のための方法
US8380531B2 (en) 2008-07-25 2013-02-19 Invivodata, Inc. Clinical trial endpoint development process
EP2369956A1 (en) * 2008-10-22 2011-10-05 Allergan, Inc. Clinical assessment scales and methods
US20110217252A1 (en) * 2008-11-11 2011-09-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound useful for treating cellulite
ES2531402T3 (es) 2008-11-19 2015-03-13 Meiji Seika Pharma Co Ltd Colagenasa de fusión a la que se une una marca de afinidad, y método para producir la misma
IT1397646B1 (it) 2009-12-15 2013-01-18 Seidita Collagenasi ricombinanti di c. histolyticum e metodo per la loro produzione.
US9132199B2 (en) 2010-03-05 2015-09-15 University of Pittsburgh—of the Commonwealth System of Higher Education Reverse thermal gels and uses therefor
US20130195828A1 (en) 2010-04-14 2013-08-01 Northwestern University Pharmaceutical Compositions and Methods for Digesting Atherosclerotic Plaques
US20120046576A1 (en) * 2010-08-19 2012-02-23 Medicis Pharmaceutical Corporation Mid-face aesthetic scale and related methods
US20130217789A1 (en) 2010-09-03 2013-08-22 North Carolina Central University Biodegradable liquogel and ph sensitive nanocarriers
ES2385239B1 (es) 2010-09-30 2013-06-19 Proteos Biotech S.L.U. Uso de colagenasa g recombinante, colagenasa h recombinante y pz-peptidasa recombinante para el tratamiento de enfermedades que cursan con alteraciones del colágeno.
US20120237492A1 (en) 2011-02-18 2012-09-20 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
WO2012125948A1 (en) 2011-03-16 2012-09-20 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
TWI461214B (zh) 2011-06-13 2014-11-21 Univ Chang Gung Biodegradable water-sensitive glue, a drug delivery system as a carrier thereof, and a pharmaceutical composition for the treatment and / or prevention of eye diseases
KR102043476B1 (ko) * 2011-10-17 2019-11-12 사운드 써지칼 테크놀로지 엘엘씨 셀룰라이트를 처리하기 위한 초음파 프로브
JP2014530873A (ja) 2011-10-21 2014-11-20 オーキシリウム インターナショナル ホールディングス,インコーポレイテッド Efpの治療または低減方法
PT2802652T (pt) 2012-01-12 2019-09-10 Endo Global Ventures Enzimas de clostridium histolyticum
WO2013112974A1 (en) * 2012-01-27 2013-08-01 Revance Therapeutics, Inc. Methods and assessment scales for measuring wrinkle severity
US9933436B2 (en) * 2012-09-07 2018-04-03 Shiseido Company, Ltd. Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicator
US20160000890A1 (en) 2013-03-15 2016-01-07 Biospecifics Technologies Corp. Thermosensitive hydrogel collagenase formulations
EP2968107B1 (en) * 2013-03-15 2019-05-08 Mary Kay, Inc. Cosmetic compositions and uses thereof
EP3834840B8 (en) * 2013-03-15 2025-09-17 Endo Biologics Limited Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
RU2662356C1 (ru) * 2014-06-27 2018-07-25 Медитокс Инк. Способы и композиции на основе желчных кислот и их солей для уменьшения количества жира
AU2017218522A1 (en) 2016-02-08 2018-08-23 OutcomeMD, Inc. Determining a wellness, improvement, or effectiveness score
ES2886651T3 (es) * 2016-10-28 2021-12-20 Merz Pharma Gmbh & Co Kgaa Tratamiento cosmético de la celulitis
EP4591945A3 (en) 2017-03-01 2026-04-15 Endo Operations Limited Apparatus and method for assessing and treating cellulite
JP7227918B2 (ja) 2017-03-28 2023-02-22 エンド ベンチャーズ リミテッド コラゲナーゼ産生の改良された方法

Similar Documents

Publication Publication Date Title
JP2020511284A5 (https=)
Richard et al. Sex‐and age‐adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the «OBJECTIFS PEAU» study
Agner et al. Classification of hand eczema
Nana et al. Multiple sclerosis in Canada 2011 to 2031: results of a microsimulation modelling study of epidemiological and economic impacts
Gorbien et al. Elder abuse and neglect: an overview
Lallas et al. Dermoscopic pattern of psoriatic lesions on specific body sites
Krzymińska-Siemaszko et al. Comparison of four sarcopenia screening questionnaires in community-dwelling older adults from Poland using six sets of international diagnostic criteria of sarcopenia
Pereira et al. Endogenous opioid-masked latent pain sensitization: studies from mouse to human
Ougrin et al. Specific psychological treatment versus treatment as usual in adolescents with self-harm
Merineau‐Cote et al. Correlates of restraint and seclusion for adults with intellectual disabilities in community services
Sonenblum et al. Some people move it, move it… for pressure injury prevention
Brodeur et al. Time estimation among low‐functioning individuals with autism spectrum disorders: Evidence of poor sensitivity to variability of short durations
Nagai et al. Near falls predict substantial falls in older adults: A prospective cohort study
Gandhi et al. Clinicoepidemiological study of dermatophyte infections in pediatric age group at a tertiary hospital in Karnataka
Montgomery et al. Mortality following unemployment during an economic downturn: Swedish register-based cohort study
Chapman et al. Mortality risk associated with personality facets of the big five and interpersonal circumplex across three aging cohorts
Loerbroks et al. Job insecurity is associated with adult asthma in Germany during Europe's recent economic crisis: a prospective cohort study
Yule et al. The International Index of Erectile Function: a methodological critique and suggestions for improvement
Pistoni et al. Keratosis lichenoides chronica: case-based review of treatment options
Wang et al. Experimental study on individual risk in crowds based on exerted force and human perceptions
Johnstone et al. Assessment of body image in obesity using a digital morphing technique
Stang et al. Site-and gender-specific time trend analyses of the incidence of skin melanomas in the former German Democratic Republic (GDR) including 19 351 cases
Lateef Estimation of fatalities due to road traffic crashes in Karachi, Pakistan, using capture-recapture method
Starrenburg et al. Psychological indices as predictors for phantom shocks in implantable cardioverter defibrillator recipients
Mamuye et al. Statistical analysis of urban quality of life (Case study: Hawassa Town, SNNP Region, Ethiopia)